Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Buy
75
NRILY Quote, Financials, Valuation and Earnings
Last price:
$38.60
Seasonality move
:
5.57%
Day range:
$36.84 - $39.26
52-week range:
$24.13 - $39.48
Dividend yield:
0.99%
P/E ratio:
35.29x
P/S ratio:
4.33x
P/B ratio:
7.56x
Volume:
21.4K
Avg. volume:
41.8K
1-year change:
51.06%
Market cap:
$21.9B
Revenue:
$5B
EPS (TTM):
$1.09
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Nomura Research Institute has -- downside to fair value with a price target of -- per share.
NRILY vs. S&P 500
-
Over the past 5 trading days, Nomura Research Institute has underperformed the S&P 500 by -2.89% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nomura Research Institute does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nomura Research Institute revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Nomura Research Institute reported revenues of $1.3B.
Earnings Growth
-
Nomura Research Institute has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Nomura Research Institute reported earnings per share of $0.30.
Enterprise value:
22.4B
EV / Invested capital:
4.89x
Price / LTM sales:
4.33x
EV / EBIT:
24.05x
EV / Revenue:
4.40x
PEG ratio (5yr expected):
3.02x
EV / Free cash flow:
34.74x
Price / Operating cash flow:
22.45x
Enterprise value / EBITDA:
17.82x
Gross Profit (TTM):
$1.8B
Return On Assets:
10%
Net Income Margin (TTM):
12.26%
Return On Equity:
22.09%
Return On Invested Capital:
13.56%
Operating Margin:
18.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $5.2B | $5.2B | $5.1B | $1.3B | $1.3B | |
| Gross Profit | $1.8B | $1.8B | $1.8B | $451.1M | $464.6M | |
| Operating Income | $827.5M | $843.1M | $869.8M | $217M | $237.9M | |
| EBITDA | $1.2B | $1.2B | $1.2B | $309.3M | $326.3M | |
| Diluted EPS | $0.93 | $1.00 | $1.03 | $0.28 | $0.30 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.9B | $2.7B | $2.6B | $2.7B | $2.8B | |
| Total Assets | $6B | $6.5B | $6.3B | $6.1B | $6.2B | |
| Current Liabilities | $1.6B | $2.4B | $1.5B | $1.4B | $1.6B | |
| Total Liabilities | $2.9B | $3.7B | $3.3B | $3.4B | $3.3B | |
| Total Equity | $3B | $2.8B | $3B | $2.7B | $2.9B | |
| Total Debt | $1.1B | $1.7B | $1.5B | $1.8B | $1.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $874.2M | $880.5M | $986M | $337.7M | $310.5M | |
| Cash From Investing | -$1.2B | -$453.1M | -$370.2M | -$127.7M | -$78.2M | |
| Cash From Financing | -$71.2M | -$332.7M | -$329.7M | -$437.1M | -$34.5M | |
| Free Cash Flow | $491.3M | $475.4M | $640.9M | $216.6M | $233.9M | |
NRILY
Sector
Market Cap
$21.9B
$78.1M
Price % of 52-Week High
97.11%
57.42%
Dividend Yield
0.99%
0%
Shareholder Yield
5.81%
0.76%
1-Year Price Total Return
51.66%
-18.92%
Beta (5-Year)
0.743
0.874
Dividend yield:
0.99%
Annualized payout:
$0.19
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$38.17
200-day SMA
Buy
Level
$32.58
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$36.12
Relative Strength Index (RSI14)
Buy
Level
67.48
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-16.696
50-day SMA
Buy
Level
$34.78
MACD (12, 26)
Buy
Level
1.28
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.491)
Buy
CA Score
(Annual)
Level (0.3009)
Buy
Beneish M-Score
(Annual)
Level (-2.5317)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.1048)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nomura Research Institute Ltd provides Consulting, Financial IT solutions, Industrial IT solutions and IT platform services. Its consulting service includes management and systems consulting. Financial IT solutions consists of securities, banking and insurance business. Industrial IT solutions cover distribution and healthcare business and manufacturing and service industries. IT platform services include IT infrastructure, System management and advanced information technology solutions.
Stock Forecast FAQ
In the current month, NRILY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NRILY average analyst price target in the past 3 months is --.
-
Where Will Nomura Research Institute Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nomura Research Institute share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Nomura Research Institute?
Analysts are divided on their view about Nomura Research Institute share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nomura Research Institute is a Sell and believe this share price will rise from its current level to --.
-
What Is Nomura Research Institute's Price Target?
The price target for Nomura Research Institute over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NRILY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nomura Research Institute is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NRILY?
You can purchase shares of Nomura Research Institute via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nomura Research Institute shares.
-
What Is The Nomura Research Institute Share Price Today?
Nomura Research Institute was last trading at $38.60 per share. This represents the most recent stock quote for Nomura Research Institute. Yesterday, Nomura Research Institute closed at $38.60 per share.
-
How To Buy Nomura Research Institute Stock Online?
In order to purchase Nomura Research Institute stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Is it Too Late to Buy Gold?
Amid deep uncertainties about the future of the US economy,…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is up 23.1% over the past day.
Sell
39
RGC alert for Apr 30
Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 14.88% over the past day.
